Vera Therapeutics, Inc. (VERA)

NASDAQ: VERA · IEX Real-Time Price · USD

42.32

+2.81 (7.11%)

At close: May 1, 2024, 4:00 PM

43.14

+0.82 (1.94%)

After-hours: May 1, 2024, 6:52 PM EDT

Vera Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	2,324	683	535	569	-	-
Market Cap Growth	-	27.69%	-5.87%	-	-	-
Enterprise Value	2,216	576	452	494	-54	-3
PE Ratio	-7.12	-7.12	-6.01	-17.43	-	-
PB Ratio	22.84	6.72	6.96	8.17	-	-
P/FCF Ratio	-7.41	-7.41	-7.91	-23.98	-	-
P/OCF Ratio	-7.41	-7.41	-7.92	-23.98	-	-
EV/EBITDA Ratio	-6.13	-6.13	-5.21	-15.23	1.01	0.27
EV/EBIT Ratio	-6.25	-6.25	-5.13	-15.15	1.01	0.26
EV/FCF Ratio	-6.25	-6.25	-6.68	-20.83	1.54	0.29
Debt / Equity Ratio	0.53	0.53	0.41	0.07	-	0.00
Debt / EBITDA Ratio	-0.57	-0.57	-0.36	-0.15	-	-0.01
Debt / FCF Ratio	-0.58	-0.58	-0.46	-0.21	-	-0.01
Quick Ratio	7.21	7.21	4.48	10.36	22.32	3.01
Current Ratio	7.71	7.71	4.91	10.73	22.55	3.36
Interest Coverage	-24.35	-24.35	-88.77	-1629.40	-320.76	-231.41
Return on Equity (ROE)	-73.30%	-73.30%	-81.20%	-84.70%	84.90%	-
Return on Assets (ROA)	-50.80%	-50.80%	-61.80%	-40.20%	-178.20%	-
Return on Capital (ROIC)	-65.65%	-65.65%	-84.02%	-46.17%	58.47%	32.85%
Earnings Yield	-4.13%	-14.05%	-16.64%	-5.74%	-	-
FCF Yield	-3.97%	-13.50%	-12.64%	-4.17%	-	-
Buyback Yield / Dilution	-60.73%	-60.73%	-97.76%	-4099.14%	-8.34%	-
Total Shareholder Return	-60.73%	-60.73%	-97.76%	-4099.14%	-8.34%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).